Ingenol mebutate is a novel approach for the treatment of actinic keratoses. This new topical approach successfully treats AKs in only two or three days, — a much shorter therapeutic regimen compared to the current readily used topical approaches, such as solaraze, 5-FU and imiquimod, and, therefore, also increases patient compliance.